NDC 0591-2258

scopolamine

Scopolamine

scopolamine is a Transdermal System in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Scopolamine.

Product ID0591-2258_668e3706-c7fe-4649-b508-2b44a388718c
NDC0591-2258
Product TypeHuman Prescription Drug
Proprietary Namescopolamine
Generic NameScopolamine
Dosage FormSystem
Route of AdministrationTRANSDERMAL
Marketing Start Date2022-05-12
Marketing CategoryANDA /
Application NumberANDA208769
Labeler NameActavis Pharma, Inc.
Substance NameSCOPOLAMINE
Active Ingredient Strength1 mg/3d
Pharm ClassesAnticholinergic [EPC], Cholinergic Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0591-2258-04

4 POUCH in 1 CARTON (0591-2258-04) > 1 PATCH in 1 POUCH > 3 d in 1 PATCH
Marketing Start Date2022-05-12
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "scopolamine" or generic name "Scopolamine"

NDCBrand NameGeneric Name
0378-6470Scopolaminescopolamine
0591-2258scopolaminescopolamine
50090-5349Scopolaminescopolamine
50742-505ScopolamineScopolamine
72689-0023KIMITEScopolamine
0067-4345Transderm Scopscopolamine
0067-4346Transderm Scopscopolamine
66758-208Transderm Scopscopolamine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.